Screening and Treatment Choices For Localized Prostate Cancer Among Expert Physicians

May 15, 2017

The Findings Are Being Presented at The American Urological Association’s Annual Scientific and Technology Meeting

Dr. Christopher Wallis, University of Toronto, Resident, Urologic Surgery, and Author of the Study

(Boston, MA., Monday, May 15, 2017) – More than 161,000 new cases of prostate cancer are expected to be diagnosed in 2017. It is estimated that one in seven men will be diagnosed with this disease in their lifetime; however, their odds increase to one in five if they are African American and one in three with they have a family history.

Prostate cancer screening and treatment choices remain highly controversial. Urologists, radiation oncologists, and medical oncologists were recently surveyed about their personal practices and recommendations to immediate family members regarding prostate cancer screening and treatment. The findings are being presented at the American Urological Association’s Annual Scientific and Technology Meeting, from May 12 to 16 in Boston, MA.

Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 21,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.

To learn more about the AUA, visit: www.AUAnet.org

Comments are closed.